Systemic lupus erythematosus · Lupus nephritis · MicroRNA-145 · Renal vascular lesion · Human vascular smooth muscle cells · PDGF-BB Abstract Aims: The current study was conducted with the central objective of investigating the expression of microRNA-145 (miR-145) in renal vascular lesions (RVLs) in juvenile lupus nephritis (JLN) and its possible mechanism. Methods: The clinical data of 49 JLN patients confirmed by renal biopsy were collected and followed by grouping according to the RVLs score after hematoxylin-eosin staining: mild, moderate, and severe groups. In situ hybridization was used to detect the expression of miR-145 in renal vessels which was then being compared among different RVLs groups. Up-LV-miR-145 and LV-miR-NC lentiviral vectors were constructed and transfected into human vascular smooth muscle cells (HVSMCs), respectively. After HVSMCs were treated with 10.0 µg/L platelet-derived growth factor (PDGF)-BB for 24 h, the proliferation, migration, and apoptosis of endothelial cells were detected by MTT, Transwell assay, and flow cytometry, respectively. Western blot was used to detect expression of alpha-smooth muscle actin (α-SM-actin) and osteopontin (OPN). Results: The expression of miR-145 in renal vascular cells was statistically significant. The higher the inner membrane ratio, the lesser the miR-145 expression. After treatment with PDGF-BB, expression of miR-145 in HVSMCs decreased, proliferation and migration ability enhanced, apoptosis decreased, α-SM-actin decreased, and OPN increased. The proliferation and migration ability of HVSMCs in the LVmiR-145 group suppressed, apoptosis enhanced, α-SM-actin increased, and OPN decreased. Conclusions: Our study revealed that miR-145 expression decreased with the increase of vascular damage. miR-145 can inhibit proliferation, migration, and differentiation phenotypic transformation of HVSMCs induced by PDGF-BB. miR-145 may be involved in the pathogenesis of RVLs and may be a new target for treatment of RVLs in lupus nephritis.
Introduction
Lupus nephritis (LN) is the most common manifestation and the major cause of death in systemic lupus erythematosus (SLE). LN is featured by glomerular deposition of immune complex accompanied with persistent inflammation [1] . As the main cause of death in patients with lupus, it is reported that LN affects approximately > 70% of the patients [2] . Statistics have indicated that most patients with nephritis are younger, and males are more susceptible to LN [3] . Moreover, Asian, African Caribbean, and African American ethnicities may suffer more severe nephritis than other ethnic groups [4] . Owing to its complex pathogenesis, LN habitually occurs due to the influence of several factors such as deposition of autoantibodies in glomerulus, production of extracellular matrix proteins, proinflammatory cytokines, and chemokines and activation of complement and macrophages, which may further lead to tubulointerstitial inflammation, tubular damage, and fibrosis [5] . Early diagnosis and treatment of LN aim to prevent the disease from developing into chronic renal failure and renal transplantation [6] . Drug treatment for LN depends on the severity of the disease; therefore, finding reliable LN biomarkers will help to assess disease activity to improve prognosis [7] .
MicroRNA (miRNA) plays a role in posttranslational regulation of gene expression through base pairing of complementary sequences and mRNA molecules [8] . In physiological or pathological conditions, such as inflammation and cancer, certain miRNAs can induce mRNA degradation and/or inhibition of protein translation [9] . Accumulating evidence has demonstrated the role of miRNAs in many kinds of kidney diseases including renal cell carcinoma, nephritic syndrome, renal fibrosis, and LN [10] . For example, decreased miR-130b was found in kidney tissues from patients and mouse model of LN, and overexpression of miR-130b could ameliorate IFNα-accelerated LN, providing potential therapeutic approaches for LN [11] . MicroRNA-145 (miR-145) was first found in the mouse heart tissue and later reported in human beings, which is located within a 4.09 kb region on human chromosome 5 (5q32-3) [12] . The miR-143/145 cluster is now considered to be multifunctional miRNAs. For example, as tumor suppressor, both miR-143 and miR-145 can promote cell apoptosis, regulate cell cycle, and inhibit tumor cell growth [13] [14] [15] . In addition, miR-145 is recognized as a characteristic tumor suppressor miRNAs with its decreased expression found in many different kinds of cancers, including breast cancer, ovarian cancer, colorectal cancer, and prostate cancer [16] [17] [18] [19] . In particular, miR-145 has been reported to act as a proinflammatory molecule in Th2-mediated allergic inflammation [20] . Despite that, the roles of miR-145 in the regulation of immune-related diseases are still largely unknown. In this study, we focused on the roles of miR-145 on renal vascular lesion (RVLs) in children with LN.
Materials and Methods

Study Subjects
From January 1, 2012, to January 1, 2017, 49 children with LN hospitalized in the Children's Nephrology Department of Xiangya Second Hospital of Central South University were included in this study, including 11 males and 38 females. The average age was 3-16 years (mean age of 8.4 ± 2.1 years old). The inclusion criteria were (1) age ≤16 years; (2) in line with the SLE diagnostic criteria recommended by the American rheumatism society in 1997 [21] , that is, 4 or more of 11 items were diagnosed as SLE, and renal biopsy was performed to confirm LN; (3) exclude infection, tumor, and connective tissue diseases. Kidney biopsy was performed in all pediatric patients. Kidney biopsy samples were fixed in 10% formaldehyde buffer, dehydrated with 75% ethanol gradient, cleaned by xylene, embedded in paraffin, dehydrated, and made into sections with a thickness of 4 μm. This study was approved by the Ethics Committee of Xiangya Second Hospital of Central South University, and the children's family members signed the informed consent.
Evaluation of RVLs
Hematoxylin-eosin staining was performed on paraffin sections of renal biopsy tissues. The characteristics of vascular lesions were observed by selecting the median or proximal sagittal section of the small/fine renal artery under optical microscope with image photographed (×400). Image-Pro Plus 6.0 (Media Cybernetics, Inc., Rockville, MD, USA) image analysis system was used for measuring the area of membrane and the total area of blood vessels. The ratio of inner membrane area to vascular area presented the thickening degree of inner membrane (the ratio of inner membrane area). The mild group showed the ratio of inner membrane ≤0.6, the moderate group was between 0.63 and 0.75, and the severe group was ≥0.75.
In situ Hybridization
In situ hybridization was used to detect the miR-145 expression in renal vessels. The probe sequence is CTGGGAAAACTGGACCGTGAGG (purchased from Changsha AI Jia Biotechnology Co., Ltd.). Paraffin section of renal biopsy tissue was dewaxed, placed in 3% H 2 O 2 at room temperature for 10 min, digested by pepsin diluted with 3% citric acid freshly at 37 ° C for 30 min, washed with 0.5 mol PBS for 3 times, 5 min each time, and then washed by distilled water 1 time for 5 min. After prehybridization at 37 ° C for 2 h, the section was added with a mixture of diluted hybridization solution and probe (1: 500) for hybridization at 55 ° C for overnight. The sections were then washed by 2× SSC for 3 times, blocked for 30 min at 37 ° C, and blocked for another 2 h at room temperature (all reagents were purchased from Wuhan Boster Biological Technology Co., LTD., Hubei, China). Subsequently, the section was developed with DAB (purchased from Fuzhou Maixin Biotechnology Development Co., Ltd., Fuzhou, China), redyed by hematoxylin, dehydrated, cleaned, and mounted by neutral gum. 
Human Vascular Smooth Muscle Cells Culture
Human vascular smooth muscle cells (HVSMCs) (purchased from the Institute of Cell Research, Shanghai Academy of Sciences, Shanghai, China) were cultured at 37 ° C with 5% CO 2 with DMEM (1×) high glucose medium supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 4,500 mg/L glucose, 10 U/mL streptomycin, and sterile mycoplasmafree (purchased from Genom biopharmaceutical technology co., Ltd., Hangzhou, China). Cell passage was conducted when cell confluency reached 80-90%.
Lentivirus Transfection and Grouping
HVSMCs were divided into LV-miR-145 group, empty vector control group (LV-NC group), and blank control group (blank group). HVSMCs in logarithmic phase were digested by 0.25% EDTA-containing trypsin and centrifuged for 10 min at 1,000 g. After counting under microscope, the cells were inoculated in the 6-well plate and incubated for 24 h. After incubation, the cells adhered to the wall and returned to normal growth state. Sterile straw was used to aspirate culture medium, and the cells were washed by PBS, followed by the addition of 1 mL lentiviral transfection reagent (negative control virus or miR-145 overexpression virus). The blank control group did not add. After 12 h incubation, the transfection reagent was replaced by normal medium and the incubation was continued. After 72 h, the transfected cells were observed under fluorescence microscope. If green fluorescence could be seen, the transfected cells could be screened by purinomycin for 2-3 weeks until the transfected cells could grow steadily. HVSMCs from the LV-miR-145 group, the LV-NC group, and the blank group were cultured in serum-free medium for 24 h after 10.0 µg/L platelet-derived growth factor (PDGF)-BB treatment. Lentiviral vectors Up-LV-miR-145 (LV-miR-145 group) and LV-miR-NC (LV-NC group) were constructed by Shanghai GeneChem Co., Ltd. (Shanghai, China).
Fluorescent Quantitative Reverse Transcription-Polymerase Chain Reaction
The cells were incubated in the12-well plate, and each group had 3 duplicated wells. When the cell confluency reached 80%, 1 mL Trizol (Invitrogen, Carlsbad, CA, USA) was added into each well to lyse the cells for 15 min and 200 mL chloroform was added to extract the total RNA. The concentration and purity of RNA were determined by enzyme labeling (Eppendorf, Hamburg, Germany). After 500 ng of RNA was taken from each well sample, the cDNA was synthesized by reverse transcription. Samples were added according to the polymerase chain reaction (PCR) preparation system and fluorescence quantitative reverse transcription-PCR was performed. The PCR reaction conditions are as follows: the template degeneration was maintained at 15 min at 95 ° C; PCR cycle template denatured for 20 s at 94 ° C; annealing at 60 ° C and extended for 34 s, with a total of 40 cycles. The melting curve is at 95 ° C for 15 min, at 60 ° C for 1 min, and 95 ° C for 15 min. The 2 -ΔΔC method was used for relative quantification. The upstream primer of miR-145 was 5'-CAGTGCGTGTCGTGGAGT-3', the downstream primer was 5'-AGGTCCAGTTCCCAGG-3', and U6 was used as internal reference with upstream primer of 5'-CTCGCTTCGCA-3', and downstream primer of ACGCTTCACGAATGGT.
3-(4,5-Dimethyl-2-Thiazolyl)-2,5-Diphenyl-2-H-Tetrazolium Bromide (MTT) Colorimetric Experiment
When the cell confluency reached 80%, the cells were washed by PBS for 2 times, digested by regular trypsin, and titrated to form a single cell suspension. Cells were counted with cell counter. The cells were then inoculated into the 96-well plate with a density of 3 × 10 3 to 6 × 10 3 cells/well (100 μL per well) for culture for 12-24 h. Subsequently, cells were added with different concentrations of PDGF-BB (0, 5.0, 10.0, 20.0 μg/L; final volume of 200 μL; purchased from Shanghai First Biochemical Pharmaceutical Co., Ltd., Shanghai, China) for incubation in 5% CO 2 incubator at 37 ° C. Six duplicated wells were set. After that, the cells were added with 20 μL MTT solution (5 mg/mL, Sigma-Aldrich Chemical Company, St Louis, MO, USA) to develop, followed by further incubation in a 5% CO 2 incubator at 37 ° C for 4 h. The culture was terminated and the culture medium was discarded. DMSO was added to each well at a dose of 150 μL, shaking gently for 10 min to promote crystallization dissolution. The absorbance values at 570 nm of each well were determined by enzyme-labeled instrument (BioRad, USA) after a time period of 24, 48, and 72 h. The experiment was repeated 3 times.
Transwell Assay
HVSMCs at absolute growth stage in the LV-miR-145 group, the LV-NC group, and the blank group as well as the control group cells were inoculated into the apical chamber of Transwell chamber (Corning Company), and then 500 μL DMEM (Beijing solarbio science and technology Co., Ltd., Beijing, China) containing 10% fetal bovine serum was added into the basolateral chamber for incubation in 5% CO 2 incubator at 37 ° C for 24 h. After that, the migration chamber was removed, the medium was discarded, and the cells that did not cross the membrane inside the chamber were gently wiped off with a cotton swab, followed by PBS washing for 3 times. The cells were then fixed with 4% paraformaldehyde for 20 min, washed by PBS for 3 times, and stained by 0.1% crystal violet for 15 min. Under optical microscope, 5 (200×) visual fields were randomly selected to count the number of cells passing through the membrane and photographed.
Flow Cytometry
HVSMCs from the LV-miR-145 group, the LV-NC group, and the blank group as well as the control group were inoculated into the 6-well plate and detected according to the instructions of apoptosis detection kit (Nanjing KeyGen Biotech Co., Ltd., Nanjing, China). Cells were digested with 0.25% trypsin (without EDTA), centrifuged, collected, washed with PBS 3 times, then added with 500 μL precooled 1× binding buffer and with a mixture of 5 μL Annexin-V-FITC and 2.5 μL PI. 
Western Blot Analysis
Protein was extracted from the cell samples. The protein samples were added with 5× loading buffer and boiled in water for 10 min. SDS-PAGE protein electrophoresis was then carried out. After electrophoresis, the protein was transferred onto PVDF membrane by wet transfer method. The membrane was then sealed in 5% evaporated milk-TBST at room temperature for 2 h. After sealing, the PVDF membrane was incubated with the rabbit anti-human alpha-smooth muscle actin (α-SM-actin; osteopontin [OPN], 1: 1,000, Cell Signaling, Boston, MA, USA) at 4 ° C overnight. After that, the membrane was washed with TBST for 3 times (each for 10 min) and added with horseradish peroxidase labeled goat anti-rabbit IgG (1: 5,000, Beijing Kangwei Biotech Co., Ltd., Beijing, China) for incubation at room temperature for 1 h. The membrane was developed via chemiluminescence, fixed, and analyzed with β-actin as reference. Statistical Analysis SPSS 19 software was used for data analysis. The measurement data were presented as mean ± SD. One-way analysis of variance was used for comparison among multiple groups (the homogeneity of variance was tested before analysis), and LSD t test was used for pairwise comparison of multiple groups/means. Value of p < 0.05 showed significant difference.
Results
Observation of RVLs in Fourty-Nine Children with LN
RVLs in children with LN mainly presented as the abscission of intima and thickening of the inner membrane. In the mild group (n = 4 cases), the endovascular intima was intact and endothelial cell hyperplasia was obvious. In the moderate group (n = 17 cases), some of the intima were damaged, but some of the intima were asymmetrical hyperplasia, and the thickness of the inner membrane was different. In the severe group (n = 28 cases), the intima was destroyed severely, and the vascular endothelial cells were found to be exfoliated and severe stenosis was observed in the lumen of the vessel; the inner membrane was obvious hyperplasia, and most of the smooth muscle cells were spindle shaped. It can be seen that the higher the degree of thickening of the inner membrane, the greater the degree of endometrial exfoliation and vascular integrity loss (Fig. 1) .
miR-145 Is Related to the Degree of RVLs in LN Children
The miR-145 expression was then detected to explore the relationship between miR-145 and degree of RVLs. miR-145 was mainly expressed in epithelial cells of proximal convoluted tubules and vascular smooth muscle cells of renal vessels (Fig. 2A) . In situ hybridization experiment showed that the higher the ratio of inner membrane, the lesser the expression of miR-145 was (Fig. 2B) . It is indicated that the miR-145 expression was related to the degree of RVLs in LN children.
Effect of PDGF-BB on Hyperplasia of HVSMCs
In order to study the mechanism of renal vascular dysplasia in LN children, we used 0, 5.0, 10.0, 20.0 µg/L PDGF-BB to treat HVSMCs. MTT assay was used to detect the proliferation of HVSMCs. The results showed that the proliferation of VSMCs increased gradually with the increase of PDGF-BB concentration at 12 and 24 h. But at 48 h, the OD value of 10.0 µg/L PDGF-BB group increased continuously, while that of 5.0 and 20.0 µg/L PDGF-BB groups decreased (Fig. 3) . In the following experiment, we chose 10.0 µg/L PDGF-BB to intervene VSMCs for 24 h as the best treatment condition.
miR-145 Expression in HVSMCs after PDGF-BB Treatment
After HVSMC was treated with 10.0 µg/L PDGF-BB for 24 h, the miR-145 expression was detected by real-time PCR. The results showed that the miR-145 expression in the PDGF-BB stimulation group was significantly lower than that in the control group (without PDGF-BB; Fig. 4 , p < 0.05). It is indicated that the miR-145 expression was negatively regulated by PDGF-BB. 
Upregulation of miR-145 Inhibits Proliferation of HVSMCs Induced by PDGF-BB
After HVSMCs were transfected by lentivirus for 72 h, obvious green fluorescence could be seen under fluorescent microscope (Fig. 5A) . The miR-145 expression in the LV-miR-145 group was 6.7 times higher than that in the control group (p < 0.05), 5.6 times higher than that in the LV-NC group (p < 0.05), but there was no significant difference in the miR-145 expression between the blank and LV-NC groups (p > 0.05; Fig. 5B ).
In order to study the effect of miR-145 on the proliferation of HVSMCs induced by PDGF-BB, HVSMCs were stably transfected with 10.0 µg/L PDGF-BB for 24 h. The survival rates of cells in the LV-miR-145, LV-NC, blank, and control groups were measured by MTT assay. The results showed that the proliferation of HVSMCs was decreased in the LV-miR-145 group compared with the blank and LV-NC groups (p < 0.05). However, there was no significant difference in proliferation of HVSMCs between the blank group and the LV-NC group (Fig. 5C ). The proliferation of HVSMCs induced by PDGF-BB was inhibited by transfection of miR-145. 
Upregulation of miR-145 Inhibits Migration of HVSMCs Induced by PDGF-BB
The migrative ability of HVSMCs in the LV-miR-145, LV-NC, blank, and control groups was detected by Transwell assay. The migrative ability of HVSMCs in the blank group was significantly enhanced than that in the control group (p < 0.05). Compared with the blank and LV-NC groups, the migrative ability of HVSMCs decreased in the LV-miR-145 group (p < 0.05), while there was no significant difference in migrative ability of HVSMCs between the blank and LV-NC groups (p > 0.05; Fig. 6 ). The results showed that migration of HVSMCs induced by PDGF-BB was inhibited by transfection of miR-145.
Upregulation of miR-145 Promotes Apoptosis in HVSMCs Induced by PDGF-BB
After stable transfection, HVSMCs were treated with 10.0 µg/L PDGF-BB for 24 h, and the apoptosis was then detected by flow cytometry. The results showed that the apoptosis rate of HVSMCs in the blank group was significantly lower than that in the control group (p < 0.05). Compared with the blank and LV-NC groups, the apoptosis rate of HVSMCs in the LV-miR-145 group increased significantly (p < 0.05). However, there was no significant difference in apoptosis rate of HVSMCs between the control group and the LV-NC group (Fig. 7) . These findings revealed that transfection of miR-145 into HVSMCs induced by PDGF-BB could promote apoptosis of HVSMCs.
Upregulation of miR-145 Inhibits Differentiation Phenotype Transformation of HVSMCs
Induced by PDGF-BB After stable transfection, 10.0 µg/L PDGF-BB was used for treating HVSMCs for 24 h. The expression of α-SM-actin and OPN was measured by Western blot analysis. The results showed that the expression of α-SM-actin was lower, while OPN was higher in the blank group than those in the control group. Compared with the blank group and the LV-NC group, α-SMactin increased and OPN decreased in the LV-miR-145 group (p < 0.05). There was no significant difference in expression of α-SM-actin and OPN between the blank and LV-NC groups (Fig. 8) . The above results demonstrated that miR-145 could prevent differentiation phenotype transformation of HVSMCs induced by PDGF-BB to a certain extent.
Discussion
LN is characterized by autoantibody-induced renal damage in patients with SLE and acted as a crucial factor in endothelial dysfunction and accelerated atherosclerosis presented by patients with SLE [22, 23] . In the recent years, miRNAs have been found to play a role in many kinds of cellular processes, including differentiation and development of autoimmune diseases [24] . Thus, in our study, we enrolled 49 pediatric patients with LN for investigating the regulatory role of miR-145 on RVLs in LN.
First, RVLs conditions were observed, and pediatric patients with LN mainly presented with the abscission of intima and thickening of the inner membrane. Evidence has been presented suggesting that RVLs including vascular endothelial injury, noninflammatory necrosis, and cellulose degeneration, which are known as the commonest causes of renal dysfunction, poor treatment, and prognosis [25] . Previous study also clarified that the renal vascular damage observed in LN patients can be caused by intima hyperplasia, or unevenly thickening of tunicae media vasorum due to intima damages [21, 26] . In addition, the presence of renal vascular changes directly affects the prognosis of patients with LN [27] . Then, the expression of miR-145 in intrarenal vessels was evaluated, and the results in our present study revealed that the higher the ratio of inner membrane, the lesser the expression of miR-145 was, and the expression of miR-145 was related to the degree of RVLs in LN children. Active SLE in the patients can activate the immune system, leading to disruption of epithelial cells, which directly affect clinical development, treatment, and prognosis of patients with LN [28, 29] . In recent years, new clues about the development and self-sustainability of LN have emerged, pointing directly to the multistep inflammatory process triggered by antichromatin antibodies (most notably anti-DNA and antinucleosome antibodies), leading to the spread of glomerular inflammation [30] . Besides, miR-145 has been proved to affect VSMC differentiation via posttranscriptional suppression of proliferation-related proteins and thus has been involved in vascular diseases [31, 32] . Furthermore, downregulated miR-145 was observed in the vascular walls accompanied with neointimal lesion formation and in cultured dedifferentiated VSMCs [33] . In line with our result, Ding et al. [25] also confirmed that the miR-145 expression decreased with the increase in tunicae media vasorum ratio. Restoring miR-145 in lipopolysaccharides-stimulated cells by addition of a miR-145 mimic protected MH7A cells against lipopolysaccharides-induced apoptosis and inflammation [34] .
In addition, with the further treatment of PDGF-BB, we also made conclusion that PDGF-BB treatment can suppress miR-145 expression in HVSMC. In addition, proliferation, migration and differentiation phenotype transformation (presented with increased α-SMactin and decreased OPN) of HVSMCs induced by PDGF-BB were inhibited by transfection of miR-145, and overexpression of PDGF-BB from glomerular mesangial cells is the upstream mechanism for RVL in juvenile lupus nephritis. PDGF-BB is a well-known regulator of mesangial cells, which is involved in nephropathy and related not only to proinflammatory but also anti-inflammatory effects [35] . Previous evidence showed that patients with IgAN had significantly increased serum PDGF-DD levels, particularly in those with early disease [36] . Additionally, VSMC proliferation and migration can be enhanced by various growth factors and cytokines, including PDGF-BB [37] . Interestingly, decreased miR-145 is found in dedifferentiated VSMCs and is also a critical regulator of proliferation and migration of VSMCs, while overexpressed miR-145 can promote cell differentiation and inhibit VSMCs proliferation [31, 32] . Previous data have indicated the ability of PDGF-BB with regard to inhibition of miR-145-5p in VSMCs, and miR-145-5p can suppress the proliferation and migration of VSMCs induced by PDGF [38] . The phenotype change of VSMC is accompanied by the accelerated migration and accumulation of extracellular matrix, resulting in the injury of neointima, which is one of the causes of various proliferative vascular lesions [39] . Verification has been previously presented indicating that miR-145 plays an important role in the expression of the VSMC contractile phenotype due to its ability of regulating the stretchinduced differentiation of VSMCs [40, 41] . Moreover, miR-145 can regulate the phenotype switch of the VSMCs in the renal interstitium [25] . PDGF was also reported to promote the proliferation of VSMCs and increase OPN expression, which inhibit α-SMA expression;
